Johnson & Johnson beats revenue, profit projections for 2Q

Johnson & Johnson beats revenue, profit projections for 2Q


Fueled by a 20 percent sales jump in its prescription drugs business, Johnson & Johnson posted a 3 percent increase in second-quarter profit. J&J's prescription medicine business, which had lagged its medical device business until a couple years ago, accounted for half its $20.83 billion in total revenue.



from Biotech News